Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- GTC Biotherapeutics Receives NASDAQ Notice
Nov 11, 2008 07:07 AM
- GTC Biotherapeutics to Webcast Corporate Presentation at the Rodman & Renshaw 10th Annual Healthcare Conference
Nov 05, 2008 09:19 AM
- GTC Biotherapeutics Reports Third Quarter 2008 Financial Results
Nov 03, 2008 08:32 AM
- GTC Signs Agreement for $15 Million Convertible Debt Financing From LFB
Nov 03, 2008 07:02 AM
- GTC Biotherapeutics to Announce Third Quarter 2008 Earnings on Monday, November 3, 2008
Oct 29, 2008 03:53 PM
- FDA Accepts ATryn(R) BLA Filing
Oct 06, 2008 08:15 AM
- FDA Assigns Priority Review to GTC Biotherapeutics' ATryn(R)
Sep 04, 2008 08:16 AM
- GTC Biotherapeutics and OVATION Pharmaceuticals Close Agreement to Market and Develop ATryn(R) in the U.S.
Aug 14, 2008 08:13 AM
- GTC Biotherapeutics Completes BLA Submission For ATryn(R)
Aug 07, 2008 03:41 PM
- GTC Biotherapeutics Reports Second Quarter 2008 Financial Results
Aug 07, 2008 08:30 AM
- Form 4 GTC BIOTHERAPEUTICS INC For: Nov 21 Filed by: COX GEOFFREY F (10K)
Nov 24, 2008 09:37 AM
- Form 4 BULLOCK FRANCIS J For: Sep 26 (10K)
Sep 29, 2008 05:38 PM
- Form 4 GTC BIOTHERAPEUTICS INC For: Sep 26 Filed by: Bechon Christian (10K)
Sep 29, 2008 05:38 PM
- Form 4 GTC BIOTHERAPEUTICS INC For: Sep 26 Filed by: MCNAMARA PAMELA W (10K)
Sep 29, 2008 05:37 PM
- Form 4 GTC BIOTHERAPEUTICS INC For: Sep 26 Filed by: GERAGHTY JAMES A (10K)
Sep 29, 2008 05:37 PM
- Form 4 MEADE HARRY For: Jul 01 (10K)
Jul 03, 2008 08:12 AM
- Form 4 GREEN JOHN B For: Jul 01 (10K)
Jul 03, 2008 08:11 AM
- Form 4 GTC BIOTHERAPEUTICS INC For: Jul 01 Filed by: COX GEOFFREY F (10K)
Jul 03, 2008 08:10 AM
- Form 4 GTC BIOTHERAPEUTICS INC For: Jul 01 Filed by: WOLOSHEN DANIEL S (10K)
Jul 03, 2008 08:09 AM
- Form 4 Scotland Richard A For: Jul 01 (10K)
Jul 03, 2008 08:08 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
GTCB
|
Compare to S&P
|
| YTD |
-86.22 %
|
-77.42 %
|
| 4 Weeks |
-70.03 %
|
-67.60 %
|
| 12 Weeks |
-76.02 %
|
-66.76 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -200.00 %
|
|
EPS Growth in Last Year: 45.45 %
|
|
Sales Growth in Last Quarter: -67.95 %
|
|
Sales Growth in Last Quarter: 13.70 %
|
|
|
